Edwards Lifesciences Corp (EW) — 10-Q Filings
All 10-Q filings from Edwards Lifesciences Corp. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Edwards Lifesciences Q3 Net Income Plunges Post-Divestiture
— Nov 5, 2025 Risk: medium
Edwards Lifesciences Corp (EW) reported net sales of $1,553.1 million for the three months ended September 30, 2025, an increase from $1,354.4 million in the pr -
Edwards Lifesciences Q2 Sales Jump 9% on Strong Device Demand
— Aug 6, 2025 Risk: medium
Edwards Lifesciences Corp reported total net sales of $1.60 billion for the second quarter ended June 30, 2025, a 9% increase compared to $1.47 billion in the s -
Edwards Lifesciences Files Q1 2025 10-Q
— May 6, 2025 Risk: low
Edwards Lifesciences Corp. filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial performance and position. Key financi -
Edwards Lifesciences Files Q3 2024 10-Q
— Nov 6, 2024 Risk: low
Edwards Lifesciences Corp. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the thi -
Edwards Lifesciences Files Q2 2024 10-Q
— Jul 31, 2024 Risk: low
Edwards Lifesciences Corp. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the company, -
Edwards Lifesciences Corp. Files 10-Q for Period Ending March 31, 2024
— Apr 29, 2024 Risk:
Edwards Lifesciences Corp (EW) filed a Quarterly Report (10-Q) with the SEC on April 29, 2024. The filing is a 10-Q report for Edwards Lifesciences Corp. for th
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX